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Purpose: The purpose of this study is to evaluate the long-term outcomes of systemic double stenting and provisional T-stenting technique that 
were used for treating true bifurcation lesions of left main coronary artery (LMT) disease with drug-eluting stents (DES, Sirolimus-eluting stent: SES 
and Paclitaxel-eluting stent: PES). 
Methods: A prospective Asian multicenter registry was set up in six high volumes Asian centers to evaluate the efficacy DES in the treatment of 
bifurcation lesions of LMT. A total of 555 patients, 555 lesions (male 72.0, mean age 68.9) with true bifurcation lesions (defined as a more than 
50% stenosis in both LAD and LCX) were treated with 2 strategies: systemic double stenting (n=354) (culotte 89, crush 21, mini-crush 150, kissing 
8, T-stenting 86) and provisional T-stenting (n=201). All patients are evaluated immediate and long-term clinical results with 6 and 12 months 
coronary angiography. 
Results: The baseline clinical characteristics between 2 groups were similar. See figure for clinical results.  
Conclusion: This study suggests that provisional T-stenting of the side branch is a feasible strategy associated with low MACE and low TLR in 
patients with LMT disease.
